Bright Peak Therapeutics


Bright Peak are developing a portfolio of first-in-class and best-in-class cytokines with optimized biological properties for the treatment of cancer and autoimmune diseases.

Industries

Headquarters

Basel, Switzerland

Employees

51-200

Links


Org chart

Fredrik Wiklund
President & CEO
Collapse
Vijaya R. Pattabiraman
Chief Technical Officer
Matt Robbins
General Counsel
Dave Cardino
Vice President of Finance
Lazar Dimitrov
Senior Vice President, Corporate Development
Sharon Gao
VP, Chemistry, Manufacturing & Controls
Suba Krishnan
Senior Vice President, Head Of Clinical Development
Jon Wigginton
President, Research and Development

Board & advisors



Offices